Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
Lung Cancer Update
00:00
The Toxicity Profile of Systemic Therapy for Metastatic Cancer
I think that's the one thing that we grapple with a little bit when we're dealing with a widely metastatic cancer versus a GBM, where you've got a bit more of a contained space. But I'm open to seeing what this looks like. The toxicity profile, of course, is very different. And again, dose of daxxyls, no walk in the park either.
Transcript
Play full episode
